JRA
Etanercept has demonstrated excellent safety and efficacy       in large scale, randomised, double blind, placebo controlled trials of patients       with RA and JRA who are refractory to other disease modifying anti-rheumatic       drugs.
Etanercept has demonstrated excellent safety and efficacy       in large scale, randomised, double blind, placebo controlled trials of  @OBJECT$         @PREDICAT$  RA and  @SUBJECT$  who are refractory to other disease modifying anti-rheumatic       drugs.